SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?


To: Steeny who wrote (706)3/1/2000 4:39:00 PM
From: Eclectus  Read Replies (2) | Respond to of 1298
 
OK...How high can CEGE go?



To: Steeny who wrote (706)3/1/2000 7:05:00 PM
From: Steven Osborne  Read Replies (1) | Respond to of 1298
 
I sold my last 25% at 48. Long since 1996. Might have left a bunch on the table, but 23, 33, 48 look much better than the 3-7 range where CEGE spent much of the last few years.
Best of luck to the longs. The lung cancer vaccine is important but their prostate cancer vaccine could be very big.



To: Steeny who wrote (706)3/2/2000 9:41:00 PM
From: Timoteo  Read Replies (1) | Respond to of 1298
 
FWIW my target is a moving one depending on company news and market reaction, but I am looking for at least $100. I have always been good at spotting value and lousy at selling; always way too soon. There is potential for all kinds of good news. Blockbuster news could send the stock rocketing.

Best,

Timoteo